Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
CAS:1260141-27-2
Molecular Formula:C21H20FN3O6S
Alias
More Information
Tak-438; 1-[5-(2-Fluorophenyl)-1-Pyridin-3-Ylsulfonylpyrrol-3-Yl]-N-Methylmethanamine,(E)-4-Oxopent-2-Enoic Acid; Vonaprazan; 5-(2-Fluorophenyl)-N-Methyl-1-(3-Pyridinylsulfonyl)-1H-Pyrrole-3-Methanamine 2-Butenedioate (Vonoprazan); 1-[5-(2-Fluorophenyl)-1-Pyridin-3-Ylsulfonylpyrrol-3-Yl]-N-Methylmethanamine; Ak-438; Vonaprazan(Tak-438); Vonoprazan(Tak-438); Vonoprazan Fumarate(Tak-438); Vonoprazan(Tak-438)1260141-27-2
Brief Introduction
Vonolazan is undoubtedly a gold withdrawing antigastric drug, however, there is also some dissatisfaction with this drug due to previous corporate R & D failures with the p-cab class of drugs and intense competition for PPIs on the market. Even then, domestic firms still took the first time to declare vonolazan.
CNY 25.8 Million
33300m²
100-500 People
CRO
CRO
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Tech Grade | - | - |
25kg /
Fibre Drum
|
Main products:
Vonoprazan Fumarate
/Methyl 2-(2-Chloro-1-Iminoethyl)Hydrazinecarboxylate
/Aprepitant
/Apremilast
/Solifenacin
/5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-c]Pyridine-2-Carboxylic acid Hydrochloride
/Avibactam Sodium
/Nintedanib
CAS:132907-72-3
Molecular Formula:C17H18ClN3O
Alias
More Information
(R)-(1-Methyl-1H-Indol-3-Yl)(4,5,6,7-Tetrahydro-1H-Benzo[D]Imidazol-6-Yl)Methanone Hydrochloride
Brief Introduction
Ramosetron hydrochloride injection is used to prevent and treat gastrointestinal symptoms such as nausea and vomiting caused by anti-cancer drug treatment.
CNY 10 Million
50-100 People
Manufacturing
Manufacturing
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Pharm Grade | - | - |
25kg /
Fibre Drum
|
Main products:
Ramosetron Hydrochloride
/Fluconazole
/Lansoprazole
/Nizatidine
/Tiopronin
/Arphamenine B
/Foscarnet Sodium
/Nicergoline
/Fexofenadine Hydrochloride
CAS:138530-94-6
Molecular Formula:C16H14F3N3O2S
Alias
More Information
(R)-Lansoprazole; 2-[[3-Methyl-4-(2,2,2-Trifluoroethoxy)Pyridin-2-Yl]Methylsulfinyl]-1H-Benzoimidazole; Dexlansoprazole; (R)-2-(3-N,N-Diisopropylamino-1-Phenylpropyl)-4-Hydroxymethylphenoxyisobutyrate; (R)-Fesoterodine Fumarate; 2-[(1R)-3-(Dipropan-2-Ylamino)-1-Phenylpropyl]-4-(Hydroxymethyl)Phenyl 2-Methylpropanoate; 2-Methyl Propanoic Acid 2-[(1R)-3-[Bis(1-Methylethyl)Amino]-1-Phenylpropyl]-4-(Hydroxymethyl) Phenyl Ester; FESO; Dexilant
Brief Introduction
Dexlansoprazole is the R-isomer of lansoprazole and a substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity. As a weak base, dexlansoprazole accumulates in the acidic environment of the secretory canaliculus of the gastric parietal cell where it is converted to an active sulfenamide form that binds to cysteine sulfhydryl groups on the luminal aspect of the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase), thereby inhibiting the pump's activity and the parietal cell secretion of H+ ions into the gastric lumen, the final step in gastric acid production.
CNY 250 Million
133200m²
100-500 People
CRO
CRO
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Pharm Grade | - | - |
25kg /
Fibre Drum
|
Main products:
R-(+)-Lansoprazole
/Erythromycin Estolate
/Erythromycin Ethylsuccinate
/Roxithromycin
/Azithromycin
/Clarithromycin
/Azathramycin
/Erythromycin,6-O-Methyl-2',4' '-bis-O-(Trimethylsilyl),9-[O-(1-Ethoxy-1-Methylethyl)Oxime]
/Dexketoprofen
/Dexketoprofen Trometamol
/Lansoprazole
/Oxiracetam
CAS:150683-30-0
Molecular Formula:C26H25ClN2O3
Alias
More Information
N-[4-(7-Chloro-5-Hydroxy-2,3,4,5-Tetrahydro-1-Benzazepine-1-Carbonyl)-3-Methylphenyl]-2-Methylbenzamide; Samsca; Benzazepine Derivative,32; N-[4-(9-Chloro-6-Hydroxy-2-Azabicyclo[5.4.0]Undeca-8,10,12-Triene-2-Carbonyl)-3-Methyl-Phenyl]-2-Methyl-Benzamide; N-[4-[(5R)-7-Chloro-5-Hydroxy-2,3,4,5-Tetrahydro-1-Benzazepine-1-Carbonyl]-3-Methylphenyl]-2-Methylbenzamide; Opc 41061; Tolvaptan Tablets
Brief Introduction
Tovaptan was developed by Otsuka company of Japan and approved by FDA in 2009 for the treatment of patients with heart failure. The trade name of tovaptan tablets is sumeka. The difficulty of its synthesis route is mainly reflected in the construction of benzo seven membered ring. The treatment of heart failure is a research hotspot, and the development of new diuretics is one of its strategic objectives. Therefore, antagonizing arginine vasopressin is an effective method to prevent the development of heart failure.
CNY 3 Million
33300m²
100-500 People
Manufacturing
Manufacturing
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Pharm Grade | - | - |
25kg /
Fibre Drum
|
Main products:
Tolvaptan
/N-[3-Fluoro-4-[(Methylamino)Carbonyl]Phenyl]-2-Methylalanine
/4-Isothiocyanato-2-(Trifluoromethyl)Benzonitrile
/L-Prolinamide
/1,2,3,4-Tetrahydro-Benzo[b]Azepin-5-one
CAS:161796-78-7
Molecular Formula:C17H18N3NaO3S
Alias
More Information
(S)-Omeprazole Sodium; Odium (R)-6-Methoxy-2-(((4-Methoxy-3,5-Dimethylpyridin-2-Yl)Methyl)Sulfinyl)Benzo[D]Imidazol-1-Ide; Esomeprazole (Sodium); 1H-Benzimidazole,5-Methoxy-2-[[(4-Methoxy-3,5-Dimethyl-2-Pyridinyl)Methyl]Sulfinyl]-,Sodium Salt; Esomeprazoleandsalts; 1H-Benzimidazole, 5-Methoxy-2-[[(4-Methoxy-3,5-Dimethyl-2-Pyridinyl)Methyl]Sulfinyl]-, Sodium Salt; Esomeprazole Sodium
Brief Introduction
(S)-Omeprazole is the (S)-enantiomer of Omeprazole a gastric proton-pump inhibitor. (S)-Omeprazole is more potent that its (R)-enantiomer and is used in the treatment of gastroesophageal reflux disease as well as gastrointestinal ulcers associated with Crohn's disease.
CNY 180 Million
466200m²
500-1000 People
Manufacturing
Manufacturing
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
![Sodium (S)-6-Methoxy-2-(((4-Methoxy-3,5-Dimethylpyridin-2-yl)Methyl)Sulfinyl)Benzo[d]Imidazol-1-ide](https://res.chemball.com/upload2/abfbdcd1-0c51-4cdd-9262-2721481849be.png)
![Sodium (S)-6-Methoxy-2-(((4-Methoxy-3,5-Dimethylpyridin-2-yl)Methyl)Sulfinyl)Benzo[d]Imidazol-1-ide](https://res.chemball.com/upload2/f90e81d7-e263-4c7a-822e-b855a8e9aea3.jpg)
![Sodium (S)-6-Methoxy-2-(((4-Methoxy-3,5-Dimethylpyridin-2-yl)Methyl)Sulfinyl)Benzo[d]Imidazol-1-ide](https://res.chemball.com/upload2/081c3b2f-d385-4fd9-b436-80ba66ceeee3.jpg)
|
||||||
| Pharm Grade | - | - |
25kg /
Fibre Drum
|
Main products:
Sodium (S)-6-Methoxy-2-(((4-Methoxy-3,5-Dimethylpyridin-2-yl)Methyl)Sulfinyl)Benzo[d]Imidazol-1-ide
/Telmisartan
/Irbesartan
/Olmesartan Medoxomi
/Valsartan
/Candesartan Cilexetil
/Esomeprazole Magnesium Trihydrate
/Lansoprazole
/5-Methoxy-2-{[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)Methyl]Sulfinyl}-1H-Benzimidazole
/Nevirapine
/Efavirenz
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!